We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Biomea Fusion Inc is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The company's lead product candidate, BMF-219, is designed to be an orally bi... Biomea Fusion Inc is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The company's lead product candidate, BMF-219, is designed to be an orally bioavailable, potent and selective irreversible inhibitor of menin, an important transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers. Show more
Ask ADVFN Intelligence (AI)
REDWOOD CITY, Calif., Oct. 01, 2024 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage biopharmaceutical company dedicated to discovering and developing novel...
REDWOOD CITY, Calif., Sept. 26, 2024 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea” or the “Company”) (Nasdaq: BMEA), a clinical-stage biopharmaceutical company dedicated to discovering and...
REDWOOD CITY, Calif., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (Nasdaq: BMEA) (“Biomea” or the “Company”), a clinical stage biopharmaceutical company focused on the discovery and...
COVALENT-111 Phase 2b on track for Q4 2024 readoutCOVALENT-112 Phase 2a on track for Q4 2024 readoutAnnouncement of the third program in obesity on track for Q3 2024 REDWOOD CITY, Calif., July...
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.98 | -8.55148342059 | 11.46 | 12.0091 | 9.09 | 1426057 | 9.91252858 | CS |
| 4 | 2.84 | 37.1727748691 | 7.64 | 12.0091 | 6.71 | 852048 | 9.20294926 | CS |
| 12 | 5.38 | 105.490196078 | 5.1 | 12.0091 | 4.96 | 783288 | 7.30272488 | CS |
| 26 | -3.55 | -25.3029223093 | 14.03 | 14.43 | 3.61 | 1056927 | 7.48623096 | CS |
| 52 | -2.3 | -17.9968701095 | 12.78 | 22.74 | 3.61 | 1080358 | 11.35494146 | CS |
| 156 | -1.34 | -11.3367174281 | 11.82 | 43.69 | 2.84 | 587896 | 15.45037413 | CS |
| 260 | -9.52 | -47.6 | 20 | 43.69 | 2.84 | 526015 | 15.45483372 | CS |
Monksdream
4 weeks ago
Zraced1
5 months ago
giveit2me
9 months ago
Invest-in-America
2 years ago
Invest-in-America
2 years ago
TheFinalCD
2 years ago
Invest-in-America
2 years ago
Bbradley8
2 years ago
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
